Literature DB >> 19793777

Treatment of massive pulmonary embolism utilizing a multidisciplinary approach: a case study.

Kevin E Griffith1, Eric Jenkins, Jonathan Haft.   

Abstract

Massive pulmonary embolism (PE) is associated, historically, with a high mortality rate.Treatment options include systemic anticoagulation, catheter-directed thrombolytic therapy, surgical embolectomy, fragmentation techniques, and catheter embolectomy. Extracorporeal membrane oxygenation (ECMO) repeatedly has demonstrated effectiveness in providing cardiopulmonary support for the patient with a massive PE too unstable to undergo thrombolysis or embolectomy. The present case study describes a morbidly obese patient, status post gastric bypass surgery, who presented with PE, and acute respiratory and cardiac failure. A description of the patient's management plan, which includes a simple, rapidly deployed ECMO system (Levitronix CentriMag And Jostra Quadrox D), systemic- and catheter-directed thrombolytic therapy and rheolytic thrombectomy (AngioJet Series 3000, Possis Medical, Minneapolis, MN).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19793777     DOI: 10.1177/0267659109346663

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  3 in total

1.  A novel wearable pump-lung device: in vitro and acute in vivo study.

Authors:  Tao Zhang; Xufeng Wei; Giacomo Bianchi; Philip M Wong; Brian Biancucci; Bartley P Griffith; Zhongjun J Wu
Journal:  J Heart Lung Transplant       Date:  2011-10-20       Impact factor: 10.247

2.  [Arteriovenous extracorporeal membrane oxygenation (ECMO). A therapeutic option for fulminant pulmonary embolism].

Authors:  J Swol; D Buchwald; A Ewers; T A Schildhauer
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-10-17       Impact factor: 0.840

3.  Thrombolytic therapy complemented by ECMO: successful treatment for a case of massive pulmonary thromboembolism with hemodynamic collapse.

Authors:  Min Ku Chon; Yong Hyun Park; Jin Hee Choi; Sang Hyun Lee; Jeong Su Kim; Jun Kim; June Hong Kim; Kook Jin Chun
Journal:  J Korean Med Sci       Date:  2014-04-25       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.